The autism spectrum disorder treatment market is classified on the basis of autism type into:
Pervasive Developmental Disorder
Childhood Disintegrative Disorder
The growth of this market is primarily attributed to the increasing prevalence of ASD. According to CDC statistics, 1 in every 68 children suffers with autism. Innovative drugs and better treatment approaches are expected to drive the growth of market in the coming years.
North America accounts for a major share of XX% in the autism spectrum disorder treatment market, followed by Europe and APAC. The study includes analysis on potential and prospects of various treatments such as behavioral, medical, dietary and early intervention. APAC is set to witness considerable growth with a CAGR of XX% in the next few years. Awareness related to these disorders and parents’ focus on overall growth including social relations of their children boosts the market growth.
The estimates and forecasts have been derived based on various inputs from primary and secondary sources. Secondary sources such as articles, whitepapers, journals and other has helped to deliver an extensive analysis in this report. To enhance the accuracy of the estimates, the data has been validated by conducting interviews with industry experts. This report on the autism spectrum disorder treatment market identifies many such insights, market opportunities, healthcare recommendations besides providing a detailed analysis of the key service providers of treatment services as well as competitive landscape.
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
2. Executive Summary
3. ASD Treatment Market Landscape
3.1. Product Benchmarking
3.2. End user profiling
3.3. Top 5 Financials Analysis
4. ASD Treatment Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. ASD Treatment Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Opportunities Analysis
5.3. Product/Market Life Cycle Analysis
6. ASD Treatment Market –By Autism Type
6.1. Autistic Disorder
6.2. Asperger Syndrome
6.3. Pervasive Developmental Disorder
6.4. Childhood Disintegrative Disorder
7. ASD Treatment Market- By Treatment Approach
7.1. Behavioral Approaches
7.2. Early Intervention
7.4. Dietary Approach
8. ASD Treatment Market -Geographic Analysis
8.2. North America
8.4. Asia Pacific
8.5. Rest of the World
9. Market Entropy
9.1. New Product Launches
9.2. M&As, Collaborations, JVs and Partnerships
10. Company Profiles (Overview, Financials, SWOT Analysis – Top 5 Companies, Developments, Product Portfolios)
10.1. Pfizer Inc.
10.3. Behavior Analysis, Inc.
10.4. Autism Therapeutics
10.5. Curemark LLC
10.6. Roche Pharmaceuticals
10.7. Autism Treatment Plus
10.9. Retrophin, Inc.
10.10. Autism Services Inc.
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11.3. Research Methodology
11.5. Compilation of Expert Insights